These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27460867)

  • 1. The Molecular Mechanism of P2Y1 Receptor Activation.
    Yuan S; Chan HC; Vogel H; Filipek S; Stevens RC; Palczewski K
    Angew Chem Int Ed Engl; 2016 Aug; 55(35):10331-5. PubMed ID: 27460867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Different Agonist-Binding Site and Activation Mechanism of the Human P2Y
    Li Y; Yin C; Liu P; Li D; Lin J
    Sci Rep; 2017 Oct; 7(1):13764. PubMed ID: 29062134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two disparate ligand-binding sites in the human P2Y1 receptor.
    Zhang D; Gao ZG; Zhang K; Kiselev E; Crane S; Wang J; Paoletta S; Yi C; Ma L; Zhang W; Han GW; Liu H; Cherezov V; Katritch V; Jiang H; Stevens RC; Jacobson KA; Zhao Q; Wu B
    Nature; 2015 Apr; 520(7547):317-21. PubMed ID: 25822790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Signaling Patterns of Allosteric Antagonism at the P2Y
    Gao ZG; Jacobson KA
    Mol Pharmacol; 2017 Nov; 92(5):613-626. PubMed ID: 28864555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BPTU, an allosteric antagonist of P2Y1 receptor, blocks nerve mediated inhibitory neuromuscular responses in the gastrointestinal tract of rodents.
    Mañé N; Jiménez-Sábado V; Jiménez M
    Neuropharmacology; 2016 Nov; 110(Pt A):376-385. PubMed ID: 27496690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different responses of the blockade of the P2Y1 receptor with BPTU in human and porcine intestinal tissues and in cell cultures.
    Traserra S; Barber C; Maclnnes J; Relea L; MacPherson LC; Cunningham MR; Vergara P; Accarino A; Kennedy C; Jimenez M
    Neurogastroenterol Motil; 2021 Jul; 33(7):e14101. PubMed ID: 33619847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demystifying P2Y
    Ciancetta A; O'Connor RD; Paoletta S; Jacobson KA
    J Chem Inf Model; 2017 Dec; 57(12):3104-3123. PubMed ID: 29182323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
    Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet P2Y
    Ribes A; Garcia C; Gratacap MP; Kostenis E; Martinez LO; Payrastre B; Sénard JM; Galés C; Pons V
    BMC Biol; 2023 Feb; 21(1):14. PubMed ID: 36721118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Molecular Mechanism Underlying Ligand Binding to the Membrane-Embedded Site of a G-Protein-Coupled Receptor.
    Yuan X; Raniolo S; Limongelli V; Xu Y
    J Chem Theory Comput; 2018 May; 14(5):2761-2770. PubMed ID: 29660291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diadenosine tetraphosphate activates P2Y
    Paquola A; Mañé N; Giron MC; Jimenez M
    Eur J Pharmacol; 2019 Jul; 855():160-166. PubMed ID: 31063775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y1 Receptor Activation of the TRPV4 Ion Channel Enhances Purinergic Signaling in Satellite Glial Cells.
    Rajasekhar P; Poole DP; Liedtke W; Bunnett NW; Veldhuis NA
    J Biol Chem; 2015 Nov; 290(48):29051-62. PubMed ID: 26475857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse signalling of the platelet P2Y
    Amison RT; Jamshidi S; Rahman KM; Page CP; Pitchford SC
    Eur J Pharmacol; 2018 May; 827():58-70. PubMed ID: 29534999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uridine adenosine tetraphosphate is a novel neurogenic P2Y1 receptor activator in the gut.
    Durnin L; Hwang SJ; Kurahashi M; Drumm BT; Ward SM; Sasse KC; Sanders KM; Mutafova-Yambolieva VN
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):15821-6. PubMed ID: 25341729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of platelet P2Y
    Arkless KL; Pan D; Shankar-Hari M; Amison RT; Page CP; Rahman KM; Pitchford SC
    Br J Pharmacol; 2024 Feb; 181(4):564-579. PubMed ID: 36694432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents.
    Yang W; Wang Y; Lai A; Qiao JX; Wang TC; Hua J; Price LA; Shen H; Chen XQ; Wong P; Crain E; Watson C; Huang CS; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
    J Med Chem; 2014 Jul; 57(14):6150-64. PubMed ID: 24931384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interaction of HIC, an agonist of P2Y1 receptor, and its role in prostate cancer apoptosis.
    Le HTT; Murugesan A; Ramesh T; Yli-Harja O; Konda Mani S; Kandhavelu M
    Int J Biol Macromol; 2021 Oct; 189():142-150. PubMed ID: 34425116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of peripheral P2Y1 receptors prevents the induction of thermal hyperalgesia via modulation of TRPV1 expression in carrageenan-induced inflammatory pain rats: involvement of p38 MAPK phosphorylation in DRGs.
    Kwon SG; Roh DH; Yoon SY; Moon JY; Choi SR; Choi HS; Kang SY; Han HJ; Beitz AJ; Lee JH
    Neuropharmacology; 2014 Apr; 79():368-79. PubMed ID: 24333674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide P2Y
    Liston TE; Hinz S; Müller CE; Holstein DM; Wendling J; Melton RJ; Campbell M; Korinek WS; Suresh RR; Sethre-Hofstad DA; Gao ZG; Tosh DK; Jacobson KA; Lechleiter JD
    Purinergic Signal; 2020 Dec; 16(4):543-559. PubMed ID: 33129204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.